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Abstract
Background: Sensing and responding to environmental changes is a central aspect of cell division regulation.
Mycobacterium tuberculosis contains eleven Ser/Thr kinases, two of which, PknA and PknB, are key signaling
molecules that regulate cell division/morphology. One substrate of these kinases is Wag31, and we previously
showed that partial depletion of Wag31 caused morphological changes indicative of cell wall defects, and that the
phosphorylation state of Wag31 affected cell growth in mycobacteria. In the present study, we further
characterized the role of the Wag31 phosphorylation in polar peptidoglycan biosynthesis.
Results: We demonstrate that the differential growth among cells expressing different wag31 alleles (wild-type,
phosphoablative, or phosphomimetic) is caused by, at least in part, dissimilar nascent peptidoglycan biosynthesis.
The phosphorylation state of Wag31 is found to be important for protein-protein interactions between the Wag31
molecules, and thus, for its polar localization. Consistent with these results, cells expressing a phosphomimetic
wag31 allele have a higher enzymatic activity in the peptidoglycan biosynthetic pathway.
Conclusions: The Wag31Mtb phosphorylation is a novel molecular mechanism by which Wag31Mtb regulates
peptidoglycan synthesis and thus, optimal growth in mycobacteria.
Background
Tuberculosis (TB) is a major health problem with a high
mortality worldwide [1]. During the infection, Mycobac-
terium tuberculosis is able to remain dormant in the
human host without causing active disease for pro-
longed periods. Despite the importance of latency in the
epidemiology and pathology of TB, it is not clear how
M. tuberculosis controls the latent state in human host.
However, to achieve, maintain, or escape from the latent
state, M. tuberculosis must carefully regulate cell divi-
sion by sensing and responding to specific signals in the
host environment. To successfully complete this essen-
tial process, the M. tuberculosis genome contains a wide
variety of transcription regulators, surface receptors, and
signaling molecules including eleven “eukaryotic-type”
Ser/Thr protein kinases (STPKs) [2]. We previously
showed that two of these kinases, PknA and PknB, are
key components of a signal transduction pathway that
regulates cell morphology [3]. One substrate of these
kinases we identified is Wag31, a homolog of the cell-
division protein DivIVA in other Gram-positive bacteria
[4,5].
DivIVA functions in cell division in many Gram-
positive bacteria, but the specific roles it plays vary in a
species-specific manner. For instance, Bacillus subtilis
DivIVA has dual functions in this microorganism: it is
required for appropriate septum placement by confining
the MinCD cell division inhibitory complex at the cell
poles in vegetative cells, and it facilitates chromosome
segregation by interacting with the oriC complex in
sporulating cells [6-8]. In contrast, DivIVA in Strepto-
myces coelicolor is essential for hyphal tip growth, and
DivIVA homologs in Corynebacterium glutamicum and
Brevibacterium lactofermentum are localized to the cell
poles and are required for their polar growth [4,9,10].
We, and others, recently demonstrated that wag31 is
an essential gene, and that Wag31 is localized at the
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showed that the partial depletion of Wag31 causes dra-
matic morphological changes indicative of defects in
polar peptidoglycan biosynthesis, and that Wag31 and
nascent peptidoglycan biosynthesis co-localize at the
cell poles, suggesting an important role of Wag31 in
polar peptidoglycan biosynthesis in Mycobacterium
smegmatis [ 1 1 ] .F i n a l l y ,e x p r e s s i o no fp h o s p h o m i m e -
tic M. tuberculosis wag31 (wag31T73EMtb)i nt h e
wag31Msm deletion mutant of M. smegmatis showed
higher growth rate than cells expressing wild-type
wag31Mtb or phosphoablative wag31T73AMtb [11].
While Wag31Mtb appears to have a role in the protec-
tion of mycobacterial cells under stress conditions [13],
these observations strongly suggested that Wag31 and
its phosphorylation plays a critical role in modulating
cell growth through regulating peptidoglycan biosynth-
esis in mycobacteria.
In the present report, we further characterize the role
of Wag31 phosphorylation. We show that the differen-
tial growth caused by the expression of different
wag31Mtb alleles (wild-type wag31Mtb, wag31T73AMtb,
and wag31T73EMtb) is due to, at least in part, dissimilar
nascent peptidoglycan biosynthesis. We further show
that the phosphorylation state of Wag31 is important
for protein-protein interaction between the Wag31Mtb
molecules, and thus, for its polar localization. In line
with these findings, we observe a higher enzymatic
activity (MraY and MurG) of peptidoglycan biosynthetic
pathway in cells expressing phosphomimetic wag31-
T73EMtb than cells expressing wild-type wag31Mtb or
phosphoablative wag31T73AMtb.
Results
Phosphorylation of Wag31 affects the polar
peptidoglycan biosynthesis in mycobacteria
Previously, we constructed a conditional wag31Msm
mutant of M. smegmatis to demonstrate that wag31 is
an essential gene [11]. When the phosphomimetic
wag31 allele of M. tuberculosis (wag31T73EMtb), as a
sole source of Wag31, was expressed in this mutant, a
higher growth rate (mean doubling time, g =4 . 3 0h )
was observed than cells expressing wild-type wag31Mtb
(g = 4.95 h), and cells expressing the phosphoablative
wag31T73AMtb allele showed the lowest growth rate
(g = 5.75 h) [11]. Since Wag31 had been suggested to
play a role in polar peptidoglycan biosynthesis [11,12],
we tested whether the differential growth phenotype
among these strains was due to, at least in part, a differ-
ence in peptidoglycan biosynthesis. To investigate this,
we cultured those M. smegmatis wag31Msm deletion
mutants expressing wag31Mtb (KMS41 in Additional file
1 (Table A1), wag31T73AMtb (KMS42) or wag31T73EMtb
(KMS43) until mid-log phase, and stained with
Vancomycin-Alexa568 conjugate (Van-Alexa568) to
examine by fluorescence microscopy with fixed exposure
time and diaphragm aperture settings. Fluorescent van-
comycin binds to the terminal D-Ala-D-Ala portion of
unincorporated, or incorporated but uncross-linked,
peptidoglycan precursors on the cell surface, and thus
has been used to identify the sites of nascent peptidogly-
can biosynthesis in Gram-positive bacteria [14]. Van-
Alexa568 signals from the polar regions of the cells
expressing wag31T73EMtb was approximately four-fold
higher than those expressing wag31T73AMtb (Figure 1).
Cells expressing the wild-type wag31Mtb allele showed
an intermediate intensity of Van-Alexa568 signals, con-
sistent with its growth phenotype [11]. Thus, this result
suggests that the phosphorylation state of Wag31 either
regulates polar peptidoglycan biosynthesis, possibly by
directly or indirectly affecting enzyme(s) in the peptido-
glycan biosynthetic pathway, or affects the level of
cross-linking of peptidoglycan leaving non-crosslinked
D-Ala-D-Ala.
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Figure 1 Effect of Wag31 phosphorylation on nascent
peptidoglycan biosynthesis. M. smegmatis wag31Msm deletion
mutants containing wild-type Ptet-wag31Mtb,P tet-wag31T73AMtb or
Ptet-wag31T73EMtb was cultured until mid-log phase and incubated
with Van-alexa568 (5 μgm l
-1) for 20 min at 37°C. Cells were washed
with PBS buffer and examined by an Olympus BX51 microscope. To
quantify the polar fluorescence intensity, DIC (middle panel) and
fluorescence (upper panel) images were superimposed to align cells
and fluorescence signals (lower panel), and the average
fluorescence density from the poles of approximately 300 cells was
determined by using the ImageJ software. Intensity of fluorescence
signals relative to that of cells expressing wild-type gfp-wag31 is
shown. p-values for the difference (one-tailed, unpaired t-tests):
wild-type Wag31Mtb vs. Wag31T73EMtb = 1.1 × 10
-4 significant, wild-
type Wag31Mtb vs. Wag31T73AMtb = 3.3 × 10
-10 significant
(significant to p < 0.05). bar, 5 μm.
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Page 2 of 10Protein-protein interactions and polar localization of
Wag31 molecules are affected by phosphorylation
The DivIVA protein from B. subtilis forms oligomers
that assemble into a highly ordered two-dimensional
network, which is proposed to create the cell polarity
needed for sporulation or tip extension [15]. More
recently, in vivo and in vitro cross-linking experiments
showed that Wag31 also forms homo-oligomers in M.
bovis BCG [12]. Because our previous and current find-
ings suggest that the phosphorylation of Wag31 play a
regulatory role in polar peptidoglycan biosynthesis
[3,11], we hypothesized that the phosphorylation state of
Wag31 may affect its oligomerization at the cell poles
by modulating interactions between Wag31 molecules,
which in turn influence the peptidoglycan biosynthesis
at the polar location.
To address this hypothesis, we first determined
whether the phosphorylation of Wag31 affects the pro-
tein-protein interaction between Wag31 molecules using
the yeast two-hybrid system [16]. Wild-type Wag31Mtb
showed interaction with itself, compatible with the find-
i n go ft h eW a g 3 1o l i g o m e r i z a t i o ni nM. bovis BCG by
Nguyen et al. (2007) (Figure 2). Interestingly, interaction
between phosphomimetic Wag31T73EMtb molecules was
approximately two-fold stronger than the one between
wild-type Wag31Mtb molecules or between phosphoabla-
tive Wag31T73AMtb molecules, supporting a role of the
phosphorylation in stimulating the interaction between
Wag31 molecules. Interaction between wild-type Wag31
molecules was similar to that of Wag31T73A molecules,
which is likely the result from lack of phosphorylation
of wild-type Wag31 in the absence of the cognate Pkn’s
in Saccharomyces cerevisiae.
Based on the yeast two-hybrid result, we predicted that
the stronger interaction between the phosphorylated
Wag31 molecules would lead to the enhanced localization
of Wag31 to the polar regions. This prediction was tested
by comparing the localization of GFP fused to Wag31Mtb,
Wag31T73AMtb, or Wag31T73EMtb in the deletion
mutants of wag31Msm expressing the corresponding wag31
allele (strains KMS69, KMS70, and KMS71). Quantifica-
tion of polar GFP signals revealed that cells with Wag31-
T73EMtb have 2.8-fold higher, and cells with wild-type
Wag31Mtb have 1.7-fold higher GFP signals than cells with
Wag31T73AMtb (Figure 3A), while this increase in polar
localization of wild-type Wag31 and Wag31T73E could
be, in part, due to altered association of Wag31 with other
unknown molecules. This difference in polar Wag31-GFP
signals was not due to difference in the expression levels
of Wag31Mtb because approximately equal levels of
Wag31Mtb (sum of GFP-fused Wag31Mtb and non-tagged
Wag31Mtb) relative to the levels of housekeeping SigAMsm
were found from these stains (Figure 3B). In addition,
such localization was not seen when GFP alone was
expressed, indicating that the GFP-Wag31 localizations
are not a GFP artifact (Additional file 2 (Fig. A1)).
To further confirm the effect of the Wag31 phosphory-
lation on its polar localization, we examined the localiza-
tion of wild-type Wag31Mtb in the presence or absence of
pknAMtb-o rpknBMtb-overexpression. We previously
showed that Wag31 was weakly phosphorylated by
PknAMtb, which was significantly enhanced by the
addition of PknBMtb in vitro [3]. Consistent with this,
pknA-overexpression only slightly increased the polar
localization of Wag31 and polar peptidoglycan biosynth-
esis (Additional file 3 (Fig. A2)). However, overexpression
of pknBMtb, which dramatically increased the phosphory-
lation of GFP-Wag31 (Figure 4 bottom panel), elevated
the polar localization of Wag31 (two-fold, upper panel)
and nascent peptidoglycan biosynthesis (1.8-fold, middle
panel) compared to cells without pknBMtb-overexpression.
T h e s ed a t af u r t h e rs u p p o r tt hat the phosphorylation of
Wag31 enhances its polar localization, which in turn
heightens polar peptidoglycan biosynthesis.
Phosphorylation of Wag31 affects the enzymatic activity
of the peptidoglycan biosynthetic pathway
Bacterial peptidoglycan synthesis is a complex process
involving many different cytoplasmic and membrane
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Figure 2 Protein-protein interaction of Wag31 molecules by
the yeast two-hybrid system. The pJZ4-G and pHZ5-NRT clones
with each wag31Mtb allele were individually transformed into the
RFY231 and the Y309 strains, respectively. Four independent
colonies from each transformation were mated, and reporter
phenotypes for protein-protein interaction were determined by
quantitative measurements of b-galactosidase activity using the
Yeast b-Galactosidase Assay Kit (Pierce). WT-WT, interaction between
Wag31Mtb-Wag31Mtb; TA-TA, interaction between Wag31T73AMtb-
Wag31T73AMtb; TE-TE, interaction between Wag31T73EMtb-
Wag31T73EMtb; Vec-WT, control containing pHZ5-NRT-wag31Mtb and
pJZ4-G vector; Vec-Vec, control containing pHZ5-NRT and pJZ4-G
vectors; Rv1102c-Rv1103c, positive control containing pHZ5-NRT-
Rv1102c and pJZ4-G-Rv1103c [39]. Data shown are from a
representative experiment done in duplicate, and data are
represented as mean +/- SEM.
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Page 3 of 10steps [17]. In Escherichia coli, the cytoplasmic steps cul-
minate in the formation of the UDP-MurNAc-(penta-
peptide) catalyzed by a series of enzymatic activities of
Mur proteins (MurA, MurB, MurC, MurD, MurE and
MurF). The membrane-associated steps are then
initiated with the formation of MurNAc-(pentapeptide)-
diphosphoryl-undecaprenol (lipid I), a reaction catalyzed
by MraY [18]. In a subsequent step by MurG, one
GlcNAc residue is added to lipid I to form GlcNAc-
MurNAc-(pentapeptide)-diphosphoryl-undecaprenol
(lipid II), which is flipped to the outer surface of the
membrane to be incorporated into the preexisting pepti-
doglycan by penicillin binding proteins. The structure of
mycobacterial peptidoglycan is believed to be similar to
that of E. coli, although it has a few differences [19].
The same appears to be true for its biosynthesis because
M. tuberculosis possesses all eight mur genes that are
present in E. coli [20].
Our results described so far suggest that the phosphor-
ylation of Wag31 has an influence on cell growth, at least
in part, by regulating its polar localization and possibly
the biosynthesis of peptidoglycan precursors. These data
led us to hypothesize that Wag31 phosphorylation regu-
lates polar peptidoglycan synthesis by affecting, directly
or indirectly, the peptidoglycan synthetic machinery. To
address this, the activity of Mur enzymes was determined
among the wag31Msm deletion mutant strains expressing
different wag31 alleles. We began with measuring the
combined activity of MraY and MurG because these
enzymes produce the final membrane-bound disacchar-
ide-pentapeptide product. Briefly, a cell envelope-enriched
fraction (P60) was purified from the wag31 deletion
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Figure 3 Effect of Wag31 phosphorylation on polar localization.A .E a c hgfp-wag31Mtb allele behind the Pacet promoter in the replicating
plasmid pMV261 (pCK174, pCK175 and pKC176) was introduced into the wag31Msm deletion mutant expressing wag31Mtb (KMS41), wag31T73AMtb
(KMS42) or wag31T73EMtb (KMS43) under a Ptet promoter, respectively. Transformants (KMS69, KMS70, and KMS71) were cultured in the presence
of tetracycline (20 ng ml
-1) until early-log phase where the expression of each gfp-wag31 allele was induced with acetamide (0.1%) for 3 hr
before cells were observed under a fluorescence microscope, and the polar GFP-Wag31 signal was measured by using ImageJ software. Top,
GFP signal from fluorescence microscopy; Middle, DIC image of the cells shown at the top panel; Bottom, enlarged overlap image of GFP signal
and DIC. Average GFP intensity from cells expressing gfp-wag31T73AMtb or gfp- wag31T73EMtb relative to those of cells expressing wild-type gfp-
wag31 is shown at the bottom. p-values for the difference in GFP signals (one-tailed, unpaired t-tests): wild-type Wag31Mtb vs. Wag31T73EMtb =
1.2 × 10
-14, significant, and wild-type Wag31Mtb vs. Wag31T73AMtb = 1.2 × 10
-36, significant (significant to p < 0.05). bar, 5 μm. B. Western blot
analysis to examine the total Wag31 levels (GFP-Wag31 from Pacet and non-tagged Wag31 from Ptet) relative to those of SigAMsm. Total protein
was purified from each strain at the same time cells were examine for fluorescence, and 20 μg of total protein was used for Western blot
analysis with the anti-Wag31 mAb, stripped of the antibody, and subsequently for another Western blot with a monoclonal antibody against the
Sig70 of E. coli RNA polymerase (Abcam). The ratio of total Wag31/SigA signal intensity from cells expressing wild-type gfp-wag31 was set as 1.
Data shown are from a representative experiment done in duplicate.
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Page 4 of 10mutant cells expressing wag31Mtb, wag31T73AMtb,o r
wag31T73EMtb (strains KMS 41, KMS42, and KMS43),
incubated with UDP-MurNAc-pentapeptide (substrate of
MraY), ATP and UDP-[
14C]GlcNAc, and then the
reaction product of MurG ([
14C]GlcNAc-MurNAc-(pen-
tapeptide)-diphosphoryl-undecaprenol, lipid II) was ana-
lyzed by TLC [21,22]. Figure 5 shows that the P60
fraction from cells expressing wag31T73EMtb produced
7.5-fold more
14C-labeled lipid II, but cells with wag31-
T73AMtb yielded 30% less of this product than cells
expressing wild-type wag31Mtb. In a repeated experiment
with independently purified P60 fractions, a similar result
was observed (the ratio of reaction product from cells
with wild-type wag31Mtb : wag31T73AMtb : wag31T73EMtb
were 1 : 0.65 : 5.3) (data not shown). These data sug-
gested that the Wag31 phosphorylation, directly or indir-
ectly, regulates the combined activity of MraY and MurG.
Consistent with this finding, we recently found in a
Raman spectroscopic analyses that cells containing
wag31T73EMtb allele had increased intensity of the
Raman peaks that have previously been attributed to
D-glutamic acid, D-alanine, and N-acetylglucosamine
components of peptidoglycan [23,24] than cells expressing
wild-type wag31Mtb, which in turn showed higher intensity
of the these peaks than cells with wag31T73AMtb [25].
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Figure 4 Localization of Wag31 and nascent peptidoglycan
biosynthesis in the presence or absence of pknBMtb-
overexpression. Early-log phase cells of M. smegmatis (KMS4)
containing pCK314 were divided into two flasks, and pknBMtb was
expressed in one of the flasks for 2 hr by adding 0.1% of acetamide.
Subsequently, both cultures were incubated with tetracycline (20 ng
ml
-1) for 2 hr to express gfp-wag31Mtb and examined by a florescent
microscope. For vancomycin staining, Van-Alexa568 (5 μg/ml) was
added to each culture at the end of tetracycline induction and
further incubated for 20 min before examining by a fluorescence
microscope. Average GFP and Van-Alex568 intensity from cells with
pknBMtb-overexpression relative to that of cells without pknBMtb-
overexpression are shown at the bottom of each panel. (p-value for
the difference in GFP signals = 1.63 × 10
-11, and for Van-Alexa568
signals = 1.82 × 10
-7). Phosphorylation of GFP-Wag31 by pknBMtb-
overexpression is shown at the bottom panel. 200 μg of total protein
was used for 2-D PAGE and Western blot analysis with a phospho-(S/T)
Q antibody, which was then stripped before conducting a subsequent
Western blot with a GFP antibody. bar, 5 μm.
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Figure 5 Effect of Wag31 phosphorylation on enzymatic
activity of MraY and MurG. The three strains used in Fig. 1 were
cultured to mid-log phase to purify a cell wall enriched envelope
fraction (P60), which was then used as the sources of lipid
(polyprenyl phosphate) and enzymes (MraY and MurG). 2 mg of P60
protein from each strain was incubated with 50 μM UDP-MurNAc-
pentapeptide and 100 μM ATP for 5 min at 28°C, and reactions
were initiated by adding 1 μCi of UDP-[
14C]GlcNAc. After 1 hr, the
quantity of radiolabeled lipid II (▶) was determined on TLC plates
(inset) by a Phosphoimager. Data shown are from a representative
experiment done in duplicate.
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Page 5 of 10An increase in the intensity of these peaks suggests an
increase in the quantity of these molecules, thus peptido-
glycan in the cell. A corresponding pattern in the inten-
sity of these peaks was also seen in the Raman spectra
from the P60 cell envelope-enriched fractions, indicating
that the increase of these molecules is localized in the
membrane.
Discussion
Our current results provide insights into a novel
mechanism for the regulation of polar peptidoglycan
synthesis in mycobacteria via differential polar localiza-
tion of Wag31 depending on its phosphorylation status.
This mechanism of the signal transduction system invol-
ving the Wag31 phosphorylation may be widespread
among Gram-positive bacteria containing DivIVA
because recent studies demonstrated that DivIVA in
Streptococcus agalactiae and Streptococcus pneumoniae
is also phosphorylated even though its function is yet to
be discovered [26,27]. Since some bacteria such as
Mycobacterium and Corynebacterium species lack MreB
[2,9] but have a rod-like shape, and insert peptidoglycan
at the cell poles instead of the helical pattern that uses
actin-like MreB homologues, our data also suggest that
Wag31 could serve as a determinant that directs pepti-
doglycan synthesis to the poles in mycobacterial cells.
Interestingly, a recent study in C. glutamicum found
that PknACglu phosphorylates, and thereby regulates, the
activity of MurC [28]. In addition, in M. tuberculosis,
GlmU, which catalyzes the formation of UDP-GlcNAc
(the substrate of MurA), is phosphorylated by PknAMtb
and PknBMtb in vitro [29], and another enzyme, MurD,
is phosphorylated by PknAMtb [30]. These findings sug-
gest that PknAMtb and PknBMtb kinases are key regula-
tory components that modulate peptidoglycan
biosynthesis and cell growth in mycobacteria via many
targets including Wag31 and Mur enzymes.
What is the molecular mechanism by which Wag31
and its phosphorylation regulate the activity of peptido-
glycan synthetic enzymes? Protein sequence alignments
of Wag31 with DivIVA homologs revealed two conserved
coiled-coil regions at the N- and C-termini, which are
interrupted by a highly variable sequence, which includes
the phosphorylation site of Wag31 [4]. Coiled-coil
domains are known to function in protein-protein inter-
actions [31], and the two coiled-coil regions in Wag31
m a yb er e s p o n s i b l ef o rt h eformation of oligomers of
Wag31 in vitro and the potential superstructure in vivo
as proposed [12,15]. These facts, taken together with our
current finding of the phosphorylation-dependent locali-
zation of Wag31 thus tempted us to propose that the
recruitment of Wag31 to the cell poles, which is mediated
by interactions between coiled-coil regions of Wag31
molecules and is enhanced by the phosphorylation,
modulates, directly or indirectly, the activity of peptidogly-
can synthetic enzymes such as MraY and MurG. It is not
clear, however, whether Wag31 affects these enzymes
through direct interactions since we failed to detect the
interactions between Mur enzymes and Wag31 (wild-type
and phospho-mutants) in the yeast two-hybrid or myco-
bacterial protein fragment complementation system [32].
In addition, we were not able to reconstitute an assay sys-
tem to test the effect of the Wag31 phosphorylation on
the enzymatic activity of MraY and MurG in vitro because
we could not purify these enzymes in E. coli,d u et ot h e
toxicity of these enzymes when overexpressed. These
negative results, however, suggested that the localization,
and thus the activity, of Wag31 in vivo in M. tuberculosis
is probably under tight regulation that involves multiple
players.
In our previous studies, we showed that Wag31 is
mainly phosphorylated during exponential phase where
transcription of the pknA/BMtb operon is high, and
remains non- or lowly-phosphorylated during stationary
phase as transcription of the pknA/BMtb operon drops
[3,11]. Thus, our current data support the following
model. When mycobacterial cells are growing rapidly as
in exponential phase, Wag31 is phosphorylated by the
PknA/BMtb kinases and strongly recruited to the cell
poles to facilitate peptidoglycan biosynthesis so that
enough peptidoglycan is produced to meet the demands
of fast growth. It is possible that PknBMtb senses this
favorable external condition by detecting muropeptides
through its PASTA repeats and regulates peptidoglycan
biosynthesis through Wag31, because, in B. subtilis,t h e
PrkC kinase, a homolog of PknBMtb with three PASTA
domains, induces germination in response to muropep-
tide fragments released by surrounding growing bacteria
[33]. In stationary phase, however, Wag31 remains non-
or lowly-phosphorylated but can still be recruited to the
cell poles and lead to polar peptidoglycan synthesis.
This idea is consistent with our observation that the
phosphoablative Wag31T73A does localize at the cell
poles (Figure 3A), and that wild-type GFP-Wag31 shows
clear localization and peptidoglycan biosynthesis at cell
poles at late stationary phase, albeit lower than in expo-
nential phase (data not shown). This model is also con-
sistent with previous reports that a fairly high capacity
for peptidoglycan biosynthesis is maintained in slow-
growing and stationary phase bacterial cells [34]. Either
way, Wag31 itself is essential for mycobacterial survival
as we observed in our previous report [11] because
Wag31 must be present and localized to the cell poles
for polar peptidoglycan synthesis.
Conclusions
This study demonstrated that Wag31Mtb phosphoryla-
tion, which is unique among DivIVA homologues,
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Page 6 of 10regulates polar peptidoglycan biosynthesis and optimal
growth of mycobacterial cells through modulating the
localization of Wag31 and the activity of peptidoglycan
biosynthetic enzymes.
Methods
Bacterial growth condition, media and strains
M. smegmatis mc
2155 cultures were grown at 37°C in
Middlebrook 7H9 liquid medium (Difco) supplemented
w i t h1 0 %A D C( 5 %( W / V )B S Af r a c t i o nV ,2 %( W / V )
glucose and 0.85% (W/V) NaCl) and 0.05% (W/V)
Tween-80, or on Middlebrook 7H9-ADC agar plates.
Kanamycin (50 μgm l
-1), hygromycin (50 μgm l
-1)o r
apramycin (50 μgm l
-1) was added to culture media as
indicated. E. coli TOP10 strain (Life Technologies) was
used as host strain for cloning experiments, and was
grown in LB broth or solid medium with kanamycin
(20 μgm l
-1).
Plasmid construction
All plasmid constructs and primers are shown in Addi-
tional file 1 and 4 (Table A1 and A2). For localization of
different forms of Wag31Mtb, wild-type gfp-wag31Mtb,
gfp-wag31T73AMtb or gfp-wag31T73EMtb was cloned
under the acetamide-inducible promoter (Pacet)i na
replicating plasmid pMV261 (Km
r) to make pCK174,
pCK175, and pCK176, respectively. The gfp gene was
amplified from pTracerCMV plasmid (Invitrogen) using
Ngfp-wag-1 and Ngfp-wag-2 primers. Genes for
Wag31Mtb, Wag31T73AMtb and Wag31T73EMtb were
amplified from plasmids pCK89, pCK90, and pCK91
using Ngfp-TBwag-3 and Ngfp-TBwag-4 primers. Sec-
ond overlap PCR to fuse gfp and each wag31Mtb gene
was conducted by using Ngfp-wag-1 and Ngfp-TBwag-4
primers. To test localization of Wag31 in the presence
of pknAMtb-o rpknBMtb-overexpression in M. smegma-
tis, wild-type gfp-wag31Mtb was cloned under tetracy-
cline-inducible promoter (Ptet) in a replicating plasmid
pMV261 (Hyg
r)t om a k ep C K 3 1 4b yu s i n gp r i m e r s
GFPWag-Bam-5 and GFPWag-Cla-Spe-3 [11]. For the
yeast two-hybrid study, each wag31Mtb allele was cloned
in frame into both pJZ4-G (pCK145, pCK143, and
pCK142) and pHZ5-NRT vectors (pCK146, pCK147,
and pCK148) [35]. Each wag31 allele was amplified by
PCR using the WagYTHF and WagYTHR primers, and
pCK89, pCK90, and pCK91 as the templates.
Nascent peptidoglycan biosynthesis and localization of
Wag31
For observation of nascent peptidoglycan biosynthesis,
the wag31Msm deletion mutant cells of M. smegmatis
containing Ptet-wag31Mtb (pCK89), Ptet-wag31T73AMtb
(pCK90), or Ptet-wag31T73EMtb (pCK91) or cells con-
taining pMV261-Ptet-wag31 (pCK314) with or without
pknAMtb-( K M S2 )o rpknBMtb-overexpression (KMS 4)
were stained with Van-Alexa568 [11]. A stock solution
of Van-alexa568 (5 mg ml
-1) was prepared according to
the manufacturer’s manual (Molecular Probes). Each
strain was cultured in 7H9 liquid medium with tetracy-
cline (20 ng ml
-1) overnight and was then inoculated
into fresh 7H9 liquid medium containing 20 ng ml
-1 of
tetracycline. Cells from each strain were taken during
mid-log phase (approximate OD600 = 0.4) and incubated
with Van-alexa568 (5 μgm l
-1) for 20 min at 37°C. For
microscopic analysis, cells were washed with PBS buffer
and examined by an Olympus BX51 microscope. Pic-
tures were taken with an Olympus DP30BW high sensi-
tivity cooled CCD camera, acquired with DP-BSW
software and processed with Adobe Photoshop CS2. To
minimize possible errors during the sampling process
and fluorescence examination, the staining procedure
was conducted in the dark, and microscopy conditions
such as exposure time and opening of the aperture dia-
phragm were fixed for all samples. For quantification of
average fluorescence intensity at the cell poles, DIC and
fluorescence images were superimposed to align cells
and fluorescence signals, and fluorescence density from
the poles of approximately 300 cells was measured and
background-corrected by using the ImageJ software.
For localization of different forms of Wag31, pMV261
containing Pacet-gfp-wag31Mtb (pCK174), Pacet-gfp-
wag31T73AMtb (pCK175) or Pacet-gfp-wag31T73EMtb
(pCK176) was electroporated into the wag31Msm dele-
tion mutant expressing wag31Mtb (KMS41), wag31-
T73AMtb (KMS42) or wag31T73EMtb (KMS43) under a
tetracycline-inducible Ptet promoter [36] at the chromo-
somal L5 attB locus, respectively. The resulting strains
(KMS69, KMS70, and KMS71) were grown in 7H9
liquid medium containing 20 ng tetracycline, and at
early-log phase (approximate OD600 = 0.2) cells were
induced with 0.1% of acetamide for 3 hr before being
transferred onto a glass slide and observed using an
Olympus BX51 florescence microscope. Quantification
of GFP signals at the cell poles of approximately 300
cells was conducted with ImageJ software similar to the
one for Van-Alexa568. Examination of the Wag31 (both
GFP-Wag31 and non-tagged Wag31) and SigAMsm pro-
tein levels at the end of acetamide induction was con-
ducted using 20 μg of total protein and Western blots
with the anti-Wag31 mAb [37] and a monoclonal anti-
body against the Sig70 subunit of E. coli RNA polymer-
ase (Abcam), which also recognizes SigA of M.
smegmatis [38]. Western signals were quantified by
using the Quantity One software (Bio-Rad). To test the
localization of wild-type Wag31 in the presence or
absence of pknAMtb-o rpknBMtb-overexpression,
pCK314 was transformed into a M. smegmatis strain
KMS2 or KMS4. Transformants were grown in 7H9
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= 0.2), split into two flasks, and 0.1% acetamide was
added to express pknAMtb or pknBMtb for 2 hr. Both cul-
tures were further incubated with tetracycline (20 ng ml
-1)
for 2 hr to express gfp-wag31Mtb. For Van-Alexa568
staining, 5 μgm l
-1 of Van-Alexa568 was added to both
cultures, and incubated for 20 min at 37°C before micro-
scopic examination. To examine the phosphorylation of
wild-type Wag31Mtb under pknBMtb-overexpression, total
protein was purified and cleaned up with the ReadyPrep
2 D Cleanup Kit (Bio-Rad). 200 μgo ft o t a lp r o t e i nf r o m
each sample was rehydrated into isoelectric focusing
strips with a pH range of 4 to 7 (Bio-Rad). Isoelectric
focusing was performed for 35,000 V-h in a PROTEAN
IEF Cell (Bio-Rad). 2-D SDS-PAGE was performed using
10% Tris-HCl gels (Bio-Rad), and immunoblot blot ana-
lysis was performed using a phospho-(S/T)Q polyclonal
antibody (Cell Signaling Technology), stripped, and then
re-probed with anti-GFP antibody (Sigma).
Yeast two-hybrid analysis
Constructs of pJZ4-G-wag31 (pCK145), pJZ4-G-
wag31T73A (pCK143) and pJZ4-G-wag31T73E (pCK142)
were individually transformed into the yeast strain
RFY231 by plating on agar minimal media lacking trypto-
phan [16]. Each of pHZ5-NRT-wag31 (pCK146), pHZ5-
NRT-wag31T73A (pCK147) and pHZ5-NRT-wag31T73E
(pCK148) was also transformed into another yeast strain
Y309 by plating on agar minimal media lacking histidine
and uracil. Four independent colonies from each trans-
formation were mated on YPD plates, re-streaked onto
minimal media lacking uracil, histidine, and tryptophan.
As negative controls, mated cells containing empty vec-
tors alone or cells containing pHZ5-NRT-wag31Mtb
(pCK146) and pJZ4-G vector were included. Mated cells
that we recently showed the interaction between Rv1102c
and Rv1103c (with pCK227 and pCK228) [39] were
included as a positive control. Quantitative measure-
ments (b-galactosidase activity in Miller unit) of interac-
tions were conducted by using the Yeast b-Galactosidase
Assay Kit (Pierce).
Enzymatic assay for peptidoglycan synthetic enzymes
The wag31Msm deletion mutants containing each
wag31Mtb allele behind the Ptet promoter (KMS41,
KMS42, and KMS43) were cultured to mid-log phase
(approximate OD600 = 0.4), and a cell-wall enriched
envelope fraction (P60) was prepared as previously
described [22]. Briefly, 8 g of harvested cells were resus-
pended in 30 ml of buffer A (50 mM MOPS (pH 8.0),
10 mM MgCl2, and 5 mM b-mercaptoethanol), and sub-
jected to probe sonication using 10 cycles of 60 sec with
90 sec cooling on ice between the cycles. After centrifu-
gation at 23,000 × g for 30 min at 4°C, the pellet was
resuspended in buffer A with 60% Percoll (GE Health-
care), followed by centrifugation at 23,000 × g for 60
min at 4°C. The upper, flocculent band was recovered
and washed with buffer A three times, to remove resi-
dual Percoll. The cell wall enriched pellet containing
cell wall and some residual membrane was then resus-
pended in buffer A using a Dounce homogenizer. These
P60 fractions were used as the sources of lipid (polypre-
nyl phosphate) and enzymes (MraY and MurG).
For enzymatic assay, reaction mixtures containing
2 mg of P60 protein from each strain, 50 μMU D P -
MurNAc-pentapeptide and 100 μM ATP in a reaction
volume of 300 μl with buffer A were incubated for
5 min at 28°C. Reactions were initiated by adding 1 μCi
of UDP-[
14C]GlcNAc (Perkin Elmer Life Sciences) and
incubated at 28°C. After 1 hr, reactions were terminated
by addition of 20 volumes of CHCl3/CH3OH (2:1), cen-
trifuged at 3,000 × g for 10 min at room temperature,
and the supernatant was mixed with 0.6 ml of dH2Oi n
a new tube. The resulting biphasic solution was centri-
fuged again and the upper, aqueous phase was dis-
carded. The bottom, organic phase was washed with 1.5
ml of CHCl3/CH3OH/H2O (3:47:48), dried under a
stream of N2 and re-dissolved in CHCl3/CH3OH/H2O/
NH4OH (65:25:3.6:0.5). The recovered radioactive mate-
rials were applied to a silica gel TLC plate, which was
developed with CHCl3/CH3OH/H2O/NH4OH
(5.6:4.2:0.68:0.27). The location and quantity of radiola-
beled lipid II ([
14C]GlcNAc-MurNAc-(pentapeptide)-
diphosphoryl-undecaprenol) on the TLC plate was
determined by using a Molecular Dynamics Typhoon
8600 Phosphoimager (Molecular Dynamics).
Additional material
Additional file 1: Table A1: List of strains and plasmids used in this
study. List of plasmid constructs and strains made for this study.
Additional file 2: Fig. A1: Control M. smegmatis expressing gfp
alone. A control experiment in M. smegmatis to show that GFP-Wag31
localization is not due to the non-specific localization of GFP itself.
Additional file 3: Fig. A2: Localization of Wag31 and nascent
peptidoglycan biosynthesis in the presence or absence of pknAMtb-
overexpression. Examination of wild-type Wag31 localization and polar
peptidoglycan biosynthesis when pknA is overexpressed in M. smegmatis.
Additional file 4: Table A2: Primers used in this study. List of primers
used to make plasmid constructs for this study.
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